Concepedia

Colleen Boyce

CB

4

Publications

429

Citations

4

H-Index

2017

Active since

Affiliations

University of Maryland, Baltimore(Current)

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Colleen Boyce is an author at University of Maryland, Baltimore specializing in immunology, medicine, and vaccine safety.

Top concepts

Publications per year

2017–2023

4

Publications

4

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito et al. · The Lancet · 2017 · 298 citations · Full text

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study

Wilbur H. Chen, Kathleen M. Neuzil, Colleen Boyce et al. · The Lancet Infectious Diseases · 2018 · 80 citations

, , +12

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial

Kirsten E. Lyke, Andrea A. Berry, Kaitlin Mason et al. · The Lancet Infectious Diseases · 2023 · 35 citations · Full text

, , +5

Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202

Cindy J. Bednasz, Charles S. Venuto, Qing Ma et al. · Antimicrobial Agents and Chemotherapy · 2019 · 16 citations · Full text

Rows per page

1–4 of 4